Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
38
FOLD Quote, Financials, Valuation and Earnings
Last price:
$9.00
Seasonality move
:
2.68%
Day range:
$8.85 - $9.12
52-week range:
$8.55 - $12.65
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.25x
P/B ratio:
14.44x
Volume:
2M
Avg. volume:
2.4M
1-year change:
-20.56%
Market cap:
$2.8B
Revenue:
$528.3M
EPS (TTM):
-$0.18
Amicus Therapeutics SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
FOLD
Amicus Therapeutics
|
05/09/2024 | 10-Q | 10-Q filing on 05/09/2024 | View Form |
|
FOLD
Amicus Therapeutics
|
11/08/2023 | 10-Q | 10-Q filing on 11/08/2023 | View Form |
|
FOLD
Amicus Therapeutics
|
08/08/2023 | 10-Q | 10-Q filing on 08/08/2023 | View Form |
|
FOLD
Amicus Therapeutics
|
05/10/2023 | 10-Q | 10-Q filing on 05/10/2023 | View Form |
|
FOLD
Amicus Therapeutics
|
11/07/2022 | 10-Q | 10-Q filing on 11/07/2022 | View Form |
|
FOLD
Amicus Therapeutics
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
FOLD
Amicus Therapeutics
|
05/10/2022 | 10-Q | 10-Q filing on 05/10/2022 | View Form |
|
FOLD
Amicus Therapeutics
|
11/09/2021 | 10-Q | 10-Q filing on 11/09/2021 | View Form |
|
FOLD
Amicus Therapeutics
|
08/05/2021 | 10-Q | 10-Q filing on 08/05/2021 | View Form |
|
FOLD
Amicus Therapeutics
|
05/10/2021 | 10-Q | 10-Q filing on 05/10/2021 | View Form |
|
FOLD
Amicus Therapeutics
|
11/05/2020 | 10-Q | 10-Q filing on 11/05/2020 | View Form |
|
FOLD
Amicus Therapeutics
|
08/10/2020 | 10-Q | 10-Q filing on 08/10/2020 | View Form |
|
FOLD
Amicus Therapeutics
|
05/07/2020 | 10-Q | 10-Q filing on 05/07/2020 | View Form |
|
FOLD
Amicus Therapeutics
|
03/02/2020 | 10-K | 10-K filing on 03/02/2020 | View Form |
|
FOLD
Amicus Therapeutics
|
11/12/2019 | 10-Q | 10-Q filing on 11/12/2019 | View Form |
|
FOLD
Amicus Therapeutics
|
08/08/2019 | 10-Q | 10-Q filing on 08/08/2019 | View Form |
|
FOLD
Amicus Therapeutics
|
05/09/2019 | 10-Q | 10-Q filing on 05/09/2019 | View Form |
|
FOLD
Amicus Therapeutics
|
02/28/2019 | 10-K | 10-K filing on 02/28/2019 | View Form |
|
FOLD
Amicus Therapeutics
|
11/05/2018 | 10-Q | 10-Q filing on 11/05/2018 | View Form |
|
FOLD
Amicus Therapeutics
|
08/07/2018 | 10-Q | 10-Q filing on 08/07/2018 | View Form |
|
FOLD
Amicus Therapeutics
|
05/09/2018 | 10-Q | 10-Q filing on 05/09/2018 | View Form |
|
FOLD
Amicus Therapeutics
|
03/01/2018 | 10-K | 10-K filing on 03/01/2018 | View Form |
|
FOLD
Amicus Therapeutics
|
11/08/2017 | 10-Q | 10-Q filing on 11/08/2017 | View Form |
|
FOLD
Amicus Therapeutics
|
08/07/2017 | 10-Q | 10-Q filing on 08/07/2017 | View Form |
|
FOLD
Amicus Therapeutics
|
05/09/2017 | 10-Q | 10-Q filing on 05/09/2017 | View Form |
|
FOLD
Amicus Therapeutics
|
03/03/2017 | 10-K | 10-K filing on 03/03/2017 | View Form |
|
FOLD
Amicus Therapeutics
|
03/01/2017 | 10-K | 10-K filing on 03/01/2017 | View Form |
|
FOLD
Amicus Therapeutics
|
11/07/2016 | 10-Q | 10-Q filing on 11/07/2016 | View Form |
|
FOLD
Amicus Therapeutics
|
08/09/2016 | 10-Q | 10-Q filing on 08/09/2016 | View Form |
|
FOLD
Amicus Therapeutics
|
05/03/2016 | 10-Q | 10-Q filing on 05/03/2016 | View Form |
|
FOLD
Amicus Therapeutics
|
02/29/2016 | 10-K | 10-K filing on 02/29/2016 | View Form |
|
FOLD
Amicus Therapeutics
|
11/04/2015 | 10-Q | 10-Q filing on 11/04/2015 | View Form |
|
FOLD
Amicus Therapeutics
|
08/05/2015 | 10-Q | 10-Q filing on 08/05/2015 | View Form |
|
FOLD
Amicus Therapeutics
|
05/05/2015 | 10-Q | 10-Q filing on 05/05/2015 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
